Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap Fransen

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Plos One|March 3, 2012
A replication study of the association between rheumatoid arthritis and deletion of the late cornified envelope genes LCE3B and LCE3CJudith G M Bergboer, Maša Umićević-Mirkov, Jaap Fransen, et al.
Rheumatology (Oxford, England)|March 5, 2011
Treatment strategies aiming at remission in early rheumatoid arthritis patients: starting with methotrexate monotherapy is cost-effectiveLydia G Schipper, Wietske Kievit, Alfons A den Broeder, et al.
The Journal of Rheumatology|January 17, 2015
Personalizing treatment targets in rheumatoid arthritis by using a simple prediction modelYvonne M R de Punder, Tim L Th A Jansen, Annelies E van Ede, et al.
Rheumatology (Oxford, England)|April 28, 2012
The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registryYvonne M R de Punder, Jaap Fransen, Wietske Kievit, et al.
Rheumatology (Oxford, England)|January 20, 2010
How to improve DAS28 use in daily clinical practice?--a pilot study of a nurse-led interventionLaura T C van Hulst, Marjonne C W Creemers, Jaap Fransen, et al.
Clinical Rheumatology|April 1, 2019
Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort studyIris J M Disveld, Sahel Zoakman, Tim L Th A Jansen, et al.
Arthritis Research & Therapy|January 5, 2021
Younger age and female gender are determinants of underestimated cardiovascular risk in rheumatoid arthritis patients: a prospective cohort studyDaphne C Rohrich, Eline H M van de Wetering, Alexander J Rennings, et al.
Annals of the Rheumatic Diseases|June 14, 2017
Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trialChantal Am Bouman, Noortje van Herwaarden, Frank Hj van den Hoogen, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosisWieneke Mt van den Hombergh, Hanneke Ka Knaapen-Hans, Frank Hj van den Hoogen, et al.
Annals of the Rheumatic Diseases|January 3, 2012
A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registryLydia G Schipper, Marloes Vermeer, Hillechiena H Kuper, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Plos One|March 3, 2012
A replication study of the association between rheumatoid arthritis and deletion of the late cornified envelope genes LCE3B and LCE3CJudith G M Bergboer, Maša Umićević-Mirkov, Jaap Fransen, et al.
Rheumatology (Oxford, England)|March 5, 2011
Treatment strategies aiming at remission in early rheumatoid arthritis patients: starting with methotrexate monotherapy is cost-effectiveLydia G Schipper, Wietske Kievit, Alfons A den Broeder, et al.
The Journal of Rheumatology|January 17, 2015
Personalizing treatment targets in rheumatoid arthritis by using a simple prediction modelYvonne M R de Punder, Tim L Th A Jansen, Annelies E van Ede, et al.
Rheumatology (Oxford, England)|April 28, 2012
The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registryYvonne M R de Punder, Jaap Fransen, Wietske Kievit, et al.
Rheumatology (Oxford, England)|January 20, 2010
How to improve DAS28 use in daily clinical practice?--a pilot study of a nurse-led interventionLaura T C van Hulst, Marjonne C W Creemers, Jaap Fransen, et al.
Clinical Rheumatology|April 1, 2019
Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort studyIris J M Disveld, Sahel Zoakman, Tim L Th A Jansen, et al.
Arthritis Research & Therapy|January 5, 2021
Younger age and female gender are determinants of underestimated cardiovascular risk in rheumatoid arthritis patients: a prospective cohort studyDaphne C Rohrich, Eline H M van de Wetering, Alexander J Rennings, et al.
Annals of the Rheumatic Diseases|June 14, 2017
Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trialChantal Am Bouman, Noortje van Herwaarden, Frank Hj van den Hoogen, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosisWieneke Mt van den Hombergh, Hanneke Ka Knaapen-Hans, Frank Hj van den Hoogen, et al.
Annals of the Rheumatic Diseases|January 3, 2012
A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registryLydia G Schipper, Marloes Vermeer, Hillechiena H Kuper, et al.
Pageof 11